Market Overview:
The global pharmaceutical acetylcysteine market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of respiratory diseases and growing demand for acetylcysteine as a nutritional supplement. Based on type, the global pharmaceutical acetylcysteine market is segmented into spray, tracheal drip, and tablet. The spray segment is expected to register the highest CAGR during the forecast period owing to its growing demand in hospitals and clinics for treating respiratory diseases. By application, the global pharmaceutical acetylcysteine market is segmented into medicine, nutritional supplements, and others (including cosmetics). The medicine segment accounted for majority share of the global pharmaceutical acetylcysteine market in 2017 and is projected to maintain its dominance during the forecast period. This can be attributed to rising use of this drug in treatment of various respiratory disorders such as chronic obstructive pulmonary disease (COPD), pneumonia, cystic fibrosis (CF), bronchiectasis etc. Geographically, North America dominates the global Pharmaceutical Acetylcystein Market followed by Europe due high prevalence rate COPD cases in these regions . Asia Pacific region has emerged as fastest growing region with highest CAGR over next 10 years due increase incidence rates COPD cases specially India & China .
Product Definition:
Pharmaceutical acetylcysteine is a medication used to help treat and prevent lung problems caused by certain types of cancer chemotherapy. It is a type of mucolytic agent.
Spray:
Spray is a fine mist and it's used for treating skin infections. It contains acetic acid which is an irritant to the infected area. The chemical burns the skin and creates an inflammatory response that helps in getting rid of infection.
Tracheal Drip:
Tracheal drip is a method of respiratory support where a continuous flow of liquid medicine is inserted into the trachea (windpipe) via a tube. The most commonly used liquids are water and sterile water-based solutions containing acetylcysteine. It allows patients to breathe on their own and helps them recover faster from an acute respiratory illness, such as pneumonia or asthma.
Application Insights:
The medicine segment held the largest share of 61.0% in 2017. Medicine is one of the major application segments due to its usage as a drug for treating different types of respiratory diseases, such as asthma and COPD. It is also used for acetaminophen overdose or when other drugs cannot be tolerated by patients owing to adverse effects or resistance problems. However, nutritional supplements are expected to be the fastest-growing segment over the forecast period due to increasing health awareness among people across various regions, especially in Asia Pacific and Europe.
In addition, growing demand for medicines that cure chronic conditions without causing any negative effects on human health may boost industry growth during future years span from 2018 to 2030 at a significant rate considering cysteine's current market size.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its dominance over the forecast period owing to high R&D investments and increasing healthcare spending by governments as well as consumers. Moreover, growing demand for cystic fibrosis drugs has led to an increase in sales of these pharmaceutical products, which is anticipated to have a positive impact on market growth over the coming years.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period due to rising healthcare expenditure by patients and their families coupled with government initiatives promoting better treatment options for various diseases through research activities at private as well as public institutes/hospitals. In addition, growing awareness regarding drug usage along with increased spending power are likely boost regional market growth during the same period.
Growth Factors:
- Increasing incidence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for acetylcysteine in the pharmaceutical market.
- Growing awareness about the benefits of acetylcysteine: There is a growing awareness among people about the benefits of acetylcysteine, which is expected to boost its demand in the pharmaceutical market.
- Rising number of clinical studies on acetylcysteine: A large number of clinical studies are being conducted on acetylcysteine, which is likely to propel its growth in the pharmaceutical market over the forecast period.
- Technological advancements in manufacturing process: The technological advancements in manufacturing process are resulting in improved quality and purity of acetylcysteine, thereby driving its growth in Pharmaceutical AcetylCysteinemarket . 5) Emerging markets offer potential opportunities: The emerging markets offer potential opportunities for growth owing to their large population base and rising disposable income levels
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Acetylcysteine Market Research Report
By Type
Spray, Tracheal Drip, Tablet
By Application
Medicine, Nutritional Supplements, Others
By Companies
Zambon, Moehs, Pharmazell, Nippon Rika, Chengyi Pharma, Wuhan Grand Hoyo, Manus Aktteva Biopharma, Zambon
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Acetylcysteine Market Report Segments:
The global Pharmaceutical Acetylcysteine market is segmented on the basis of:
Types
Spray, Tracheal Drip, Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medicine, Nutritional Supplements, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zambon
- Moehs
- Pharmazell
- Nippon Rika
- Chengyi Pharma
- Wuhan Grand Hoyo
- Manus Aktteva Biopharma
- Zambon
Highlights of The Pharmaceutical Acetylcysteine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spray
- Tracheal Drip
- Tablet
- By Application:
- Medicine
- Nutritional Supplements
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Acetylcysteine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acetylcysteine is a medication used to treat acetaminophen overdose. It helps the liver remove the acetaminophen from the body.
Some of the major companies in the pharmaceutical acetylcysteine market are Zambon, Moehs, Pharmazell, Nippon Rika, Chengyi Pharma, Wuhan Grand Hoyo, Manus Aktteva Biopharma, Zambon.
The pharmaceutical acetylcysteine market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Acetylcysteine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Acetylcysteine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Acetylcysteine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Acetylcysteine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Acetylcysteine Market Size & Forecast, 2018-2028
4.5.1 Pharmaceutical Acetylcysteine Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Acetylcysteine Market Absolute $ Opportunity
Chapter 5 Global Pharmaceutical Acetylcysteine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmaceutical Acetylcysteine Market Size Forecast by Type
5.2.1 Spray
5.2.2 Tracheal Drip
5.2.3 Tablet
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmaceutical Acetylcysteine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmaceutical Acetylcysteine Market Size Forecast by Applications
6.2.1 Medicine
6.2.2 Nutritional Supplements
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Acetylcysteine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Acetylcysteine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmaceutical Acetylcysteine Analysis and Forecast
9.1 Introduction
9.2 North America Pharmaceutical Acetylcysteine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmaceutical Acetylcysteine Market Size Forecast by Type
9.6.1 Spray
9.6.2 Tracheal Drip
9.6.3 Tablet
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmaceutical Acetylcysteine Market Size Forecast by Applications
9.10.1 Medicine
9.10.2 Nutritional Supplements
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmaceutical Acetylcysteine Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmaceutical Acetylcysteine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmaceutical Acetylcysteine Market Size Forecast by Type
10.6.1 Spray
10.6.2 Tracheal Drip
10.6.3 Tablet
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmaceutical Acetylcysteine Market Size Forecast by Applications
10.10.1 Medicine
10.10.2 Nutritional Supplements
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmaceutical Acetylcysteine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmaceutical Acetylcysteine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmaceutical Acetylcysteine Market Size Forecast by Type
11.6.1 Spray
11.6.2 Tracheal Drip
11.6.3 Tablet
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmaceutical Acetylcysteine Market Size Forecast by Applications
11.10.1 Medicine
11.10.2 Nutritional Supplements
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmaceutical Acetylcysteine Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmaceutical Acetylcysteine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmaceutical Acetylcysteine Market Size Forecast by Type
12.6.1 Spray
12.6.2 Tracheal Drip
12.6.3 Tablet
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmaceutical Acetylcysteine Market Size Forecast by Applications
12.10.1 Medicine
12.10.2 Nutritional Supplements
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmaceutical Acetylcysteine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmaceutical Acetylcysteine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmaceutical Acetylcysteine Market Size Forecast by Type
13.6.1 Spray
13.6.2 Tracheal Drip
13.6.3 Tablet
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmaceutical Acetylcysteine Market Size Forecast by Applications
13.10.1 Medicine
13.10.2 Nutritional Supplements
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Acetylcysteine Market: Competitive Dashboard
14.2 Global Pharmaceutical Acetylcysteine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zambon
14.3.2 Moehs
14.3.3 Pharmazell
14.3.4 Nippon Rika
14.3.5 Chengyi Pharma
14.3.6 Wuhan Grand Hoyo
14.3.7 Manus Aktteva Biopharma
14.3.8 Zambon
